Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
14 p, 657.9 KB Cardiopoietic cell therapy for advanced ischaemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial / Bartunek, Jozef (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Terzic, Andre (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Davison, Beth A. (Momentum Research, Inc, Durham, NC, USA) ; Filippatos, Gerasimos S. (National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece) ; Radovanovic, Slavica (University Hospital Center Bezanijska Kosa, Belgrade, Serbia) ; Beleslin, Branko (Cardiology Clinic, Clinical Centre of Serbia, Medical School, University of Belgrade, Belgrade, Serbia) ; Merkely, Bela (Semmelweis University Heart and Vascular Center, Budapest, Hungary) ; Musialek, Piotr (Jagiellonian University Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland) ; Wojakowski, Wojciech (Third Division of Cardiology, Medical University of Silesia, Katowice, Poland) ; Andreka, Peter (Gottsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary) ; Horvath, Ivan G. (Heart Institute, University of Pécs, Pécs, Hungary) ; Katz, Amos (Department of Cardiology, Barzilai Medical Center, Israel Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel) ; Dolatabadi, Dariouch (Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium) ; El Nakadi, Badih (Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium) ; Arandjelovic, Aleksandra (Cardiology Department, Clinical Hospital Zvezdara, Belgrade, Serbia) ; Edes, Istvan (Department of Cardiology, University of Debrecen, Debrecen, Hungary) ; Seferovic, Petar M. (University of Belgrade School of Medicine, Belgrade University Medical Center, Belgrade, Serbia) ; Obradovic, Slobodan (Clinic of Emergency Medicine, Military Medical Academy, School of Medicine, University of Defense, Belgrade, Serbia) ; Vanderheyden, Marc (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Jagic, Nikola (Clinical Center Kragujevac, Kragujevac, Serbia) ; Petrov, Ivo (Department of Cardiology, Angiology, and Electrophysiology, City Clinic Heart and Vascular Institute, Sofia University, Sofia, Bulgaria) ; Atar, Shaul (Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel) ; Halabi, Majdi (Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel) ; Gelev, Valeri L. (Department of Cardiology, Angiology, and Electrophysiology, City Clinic Heart and Vascular Institute, Sofia University, Sofia, Bulgaria) ; Shochat, Michael K. (Heart Institute, Hillel Yaffe Medical Center, Hadera, Rappaport School of Medicine, Haifa, Israel, Technion) ; Kasprzak, Jaroslaw D. (Department of Cardiology Medical University of Lodz, Lodz, Poland) ; Sanz-Ruiz, Ricardo (Hospital General Universitario Gregorio Marañón) ; Heyndrickx, Guy R. (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Nyolczas, Noémi (Medical Centre, Hungarian Defense Forces, Budapest, Hungary) ; Legrand, Victor (Department of Cardiology, Centre Hospitalier Universitaire de Liège, Liège, Belgium) ; Guédès, Antoine (Department of Cardiology, Universite Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium) ; Heyse, Alex (Department of Cardiology, AZ Glorieux, Ronse, Belgium) ; Moccetti, Tiziano (Cardiocentro Ticino, Lugano, Switzerland) ; Fernandez-Aviles, Francisco (Hospital General Universitario Gregorio Marañón) ; Jimenez-Quevedo, Pilar (Hospital Clínico San Carlos (Madrid)) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hernandez-Garcia, Jose Maria (Hospital Clinico Universitario Virgen de la Victoria, Malaga, Spain) ; Ribichini, Flavio (Department of Cardiology, University of Verona, Italy) ; Gruchala, Marcin (Department of Cardiology, Medical University of Gdansk, Gdansk, Poland) ; Waldman, Scott A. (Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA) ; Teerlink, John R. (School of Medicine, University of California San Francisco and Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA) ; Gersh, Bernard J. (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Povsic, Thomas J. (Duke Clinical Research Institute and Duke Medicine, Durham, NC, USA) ; Henry, Timothy D. (Cedars Sinai Heart Institute, Los Angeles, CA, USA) ; Metra, Marco (Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University and Spedali Civili, Brescia, Italy) ; Hajjar, Roger J. (Mount Sinai School of Medicine, New York, NY, USA) ; Tendera, Michal (Third Division of Cardiology, Medical University of Silesia, Katowice, Poland) ; Behfar, Atta (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Alexandre, Bertrand (Celyad, Mont Saint Guibert, Belgium) ; Seron, Aymeric (Celyad, Mont Saint Guibert, Belgium) ; Stough, Wendy Gattis (Departments of Clinical Research and Pharmacy Practice, Campbell University College of Pharmacy and Health Sciences, Cary, NC, USA) ; Sherman, Warren (Celyad, Mont Saint Guibert, Belgium) ; Cotter, Gad (Momentum Research, Inc, Durham, NC, USA) ; Wijns, William (The Lambe Institute for Translational Medicine and Curam, National University of Ireland Galway and Saolta University Healthcare Group, Galway, Ireland) ; Universitat Autònoma de Barcelona
Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort. [...]
2016 - 10.1093/eurheartj/ehw543
European heart journal, Vol. 38 (december 2016) , p. 648-660  
2.
15 p, 2.8 MB Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload / Oommen, Saji (Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic) ; Yamada, Satsuki (Division of Cardiovascular Diseases, Mayo Clinic) ; Cantero Peral, Susana (Universitat Autònoma de Barcelona) ; Campbell, Katherine A (Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic) ; Bruinsma, Elizabeth S (General Internal Medicine and Transplant Center, Mayo Clinic) ; Terzic, Andre (Department of Medical Genetics, Mayo Clinic) ; Nelson, Timothy J (Department of Medicine, Mayo Clinic)
Stem cell therapy has emerged as potential therapeutic strategy for damaged heart muscles. Umbilical cord blood (UCB) cells are the most prevalent stem cell source available, yet have not been fully tested in cardiac regeneration. [...]
2015 - 10.1186/s13287-015-0044-y
Stem cell research & therapy, Vol. 6 (March 2015) , art. 50  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.